Satellos Bioscience Inc. logo

Satellos Bioscience Inc.

MSLE | NASDAQ
Chart Builder DCF Calculator
$6.75
+$0.05 (+0.75%)
Nov 2, 2026, 11:10 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
-24.87M -19.58M -15.89M -8.34M -12.16M -1.58M
Depreciation & Amortization
4K 13.94K 5.28K 248.31K 129.95K 422.95
Stock-Based Compensation
3.24M 1.47M 1.64M 1.06M 761.97K n/a
Other Working Capital
-1.54M -684.23K 521.63K 533.45K -328.03K 6.58K
Other Non-Cash Items
-484K 1.4M -446.31K 639.59K 7.7M 101.28K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.48M -714.19K 278.15K 730.18K -380.89K -183.34K
Operating Cash Flow
-23.6M -17.4M -14.42M -5.66M -3.95M -1.66M
Capital Expenditures
-6K -4.18K -18K -2.21K -5.68K n/a
Cash Acquisitions
n/a n/a n/a n/a 1.37M n/a
Purchase of Investments
-23.37M -26.01M -13.21M n/a n/a n/a
Sales Maturities Of Investments
13.96M 30.43M n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -4.32M n/a n/a n/a
Investing Cash Flow
-9.42M 4.42M -17.54M -2.21K 1.36M n/a
Debt Repayment
n/a n/a -284.02K n/a 146.33K 1.09M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 7.44M 26.77M 702.63K 145.46K n/a
Financial Cash Flow
2.24M 37.27M 50.95M 2.75M 5.84M 1.98M
Net Cash Flow
-30.27M 24.8M 21.27M -1.17M 3.26M -265.69K
Free Cash Flow
-23.6M -17.41M -14.44M -4.26M -3.95M -1.66M
Adj. Free Cash Flow
-26.84M -18.88M -16.07M -5.32M -4.72M -1.66M
Maintenance CapEx
-4K -4.18K -5.28K -2.21K -5.68K n/a
Growth CapEx
-2K n/a -12.72K n/a n/a n/a
Owner Earnings
-23.6M -17.41M -14.42M -4.26M -3.95M -1.66M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.